Michal Vráblík

8.0k total citations
167 papers, 2.0k citations indexed

About

Michal Vráblík is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Michal Vráblík has authored 167 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Surgery, 53 papers in Endocrinology, Diabetes and Metabolism and 39 papers in Cancer Research. Recurrent topics in Michal Vráblík's work include Lipoproteins and Cardiovascular Health (90 papers), Cancer, Lipids, and Metabolism (38 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers). Michal Vráblík is often cited by papers focused on Lipoproteins and Cardiovascular Health (90 papers), Cancer, Lipids, and Metabolism (38 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers). Michal Vráblík collaborates with scholars based in Czechia, United States and Italy. Michal Vráblík's co-authors include R Češka, Jaroslav A. Hubáček, Maciej Banach, Lukáš Zlatohlávek, Věra Adámková, Aleš Hořínek, Tomáš Štulc, Tomáš Freiberger, Dana Dlouhá and Željko Reiner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Michal Vráblík

147 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Vráblík Czechia 26 946 501 387 343 257 167 2.0k
Danish Saleheen Pakistan 22 796 0.8× 561 1.1× 782 2.0× 410 1.2× 303 1.2× 45 2.4k
Kathleen Wyne United States 21 986 1.0× 994 2.0× 460 1.2× 565 1.6× 272 1.1× 64 2.5k
Marcelo Chiara Bertolami Brazil 25 685 0.7× 385 0.8× 345 0.9× 224 0.7× 193 0.8× 71 1.9k
Emma A. Meagher United States 16 683 0.7× 393 0.8× 322 0.8× 278 0.8× 244 0.9× 47 1.8k
Günther Silbernagel Austria 30 1.0k 1.1× 804 1.6× 563 1.5× 491 1.4× 181 0.7× 95 2.7k
Daoquan Peng China 30 682 0.7× 556 1.1× 593 1.5× 593 1.7× 333 1.3× 101 2.2k
Juan F. Ascaso Spain 25 945 1.0× 1.1k 2.1× 446 1.2× 392 1.1× 247 1.0× 147 2.6k
György Paragh Hungary 29 504 0.5× 401 0.8× 433 1.1× 547 1.6× 157 0.6× 136 2.7k
Jean Bergeron Canada 29 1.3k 1.4× 989 2.0× 620 1.6× 512 1.5× 382 1.5× 80 2.9k
Constantine E. Kosmas United States 23 533 0.6× 422 0.8× 501 1.3× 254 0.7× 161 0.6× 57 1.6k

Countries citing papers authored by Michal Vráblík

Since Specialization
Citations

This map shows the geographic impact of Michal Vráblík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Vráblík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Vráblík more than expected).

Fields of papers citing papers by Michal Vráblík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Vráblík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Vráblík. The network helps show where Michal Vráblík may publish in the future.

Co-authorship network of co-authors of Michal Vráblík

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Vráblík. A scholar is included among the top collaborators of Michal Vráblík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Vráblík. Michal Vráblík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bogsrud, Martin P., Kjetil Retterstøl, Elisabeth Kleivhaug Vesterbekkmo, et al.. (2025). Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study. BMJ Open. 15(4). e092208–e092208. 1 indexed citations
3.
Katsiki, Niki, Michal Vráblík, Maciej Banach, & Ioanna Gouni‐Berthold. (2023). Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a). Pharmaceuticals. 16(4). 577–577. 35 indexed citations
4.
Oreská, Sabína, Hana Štorkánová, Jaroslav Kudlička, et al.. (2023). Cardiovascular risk in myositis patients compared with the general population. Lara D. Veeken. 63(3). 715–724. 9 indexed citations
5.
6.
Vráblík, Michal, Bohumil Seifert, Alexander Parkhomenko, et al.. (2021). Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study. Atherosclerosis. 334. 66–75. 42 indexed citations
7.
Vráblík, Michal, Alberico L. Catapano, Olov Wiklund, et al.. (2019). Understanding the Patient Perception of Statin Experience: A Qualitative Study. Advances in Therapy. 36(10). 2723–2743. 4 indexed citations
8.
Vráblík, Michal. (2019). Current and future trends in the treatment of dyslipidemias. Vnitřní lékařství. 65(10). 643–650. 2 indexed citations
9.
Vráblík, Michal, et al.. (2019). Atherosclerosis and beta-blockade: A forgotten option?. Vnitřní lékařství. 65(12). 795–801. 2 indexed citations
10.
Češka, R, Miloš Táborský, & Michal Vráblík. (2018). Společné stanovisko odborných společností k předepisování inhibitorů PCSK9. Cor et Vasa. 60(5). 649–653.
11.
12.
Freiberger, Tomáš, Lukáš Tichý, Vladimír Soška, et al.. (2017). [Familial hypercholesterolemia in the Czech Republic in 2016].. PubMed. 62(11). 924–928. 1 indexed citations
13.
Soška, Vladimír, Michal Vráblík, V. Bláha, et al.. (2016). [PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement].. PubMed. 62(4). 329–33. 1 indexed citations
14.
Vráblík, Michal, et al.. (2015). [Dietary changes in relationship to risk factors and coronary heart disease mortality].. PubMed. 61(9). 815–20. 1 indexed citations
15.
Freiberger, Tomáš & Michal Vráblík. (2015). [Early diagnosis of familial hypercholesterolemia in Czech Republic in pursuance of MedPed Project].. PubMed. 61(11). 942–5. 2 indexed citations
16.
Soška, Vladimír, H Vaverková, Michal Vráblík, et al.. (2013). Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011. Interní medicína pro praxi. 15(10). 322–326.
17.
Vráblík, Michal. (2013). Komentář k Evropským doporučeným postupům prevence kardiovaskulárních onemocnění v klinické praxi, verze 2012. Interní medicína pro praxi. 14(12). 489–490. 1 indexed citations
18.
Vráblík, Michal. (2012). Adherence v léčbě hypertenze: pomohou nové lékové formy?. Interní medicína pro praxi. 14(11). 415–418. 1 indexed citations
19.
Fait, T, et al.. (2006). [Effect of early onset of transdermal and oral estrogen therapy on the lipid profile: a prospective study with cross-over design].. PubMed. 71(3). 226–30. 1 indexed citations
20.
Vráblík, Michal, R Češka, & Aleš Hořínek. (2001). Major apoliprotein B-100 mutations in lipoprotein metabolism and atherosclerosis. Physiological Research. 337–343. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danish Saleheen Breakdown of academic impact, for papers by Kathleen Wyne Breakdown of academic impact, for papers by Marcelo Chiara Bertolami Breakdown of academic impact, for papers by Emma A. Meagher Breakdown of academic impact, for papers by Günther Silbernagel Breakdown of academic impact, for papers by Daoquan Peng Breakdown of academic impact, for papers by Juan F. Ascaso Breakdown of academic impact, for papers by György Paragh Breakdown of academic impact, for papers by Jean Bergeron Breakdown of academic impact, for papers by Constantine E. Kosmas
Rankless by CCL
2026